| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.33 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |